ArticleHuman vaccines & immunotherapeutics2025

Real-world study: Analysis of post-marketing safety for recombinant zoster vaccine in Shandong, China.

Han Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.